Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen in moderate COVID-19
PACTR202202880140319Phase 1Recruiting
- Sponsor
- Ain Shams University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ibuprofen in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Ain Shams University. Primary endpoint: Improvement and discharge to home. Started Jan 2022; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202202880140319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202202880140319.